Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cladribine and Rituximab in Hairy Cell Leukemia
NCT02157181Phase 2Completed
- Start
- Jun 2004
- Primary completion
- Sep 2012
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cladribine, rituximab in hairy cell leukemia (HCL), Hairy cell leukemia variant (HCL-V). Started Jun 2004; status: completed.
02
Drugs
cladribinerituximab
03
Conditions
hairy cell leukemia (HCL)Hairy cell leukemia variant (HCL-V)
Beyond the preview
Go deeper on NCT02157181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02157181.